Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Frontage Holdings (1521 HK)
Watchlist
60
Analysis
Health Care
•
China
Frontage Holdings Corporation operates as a biotechnology company. The Company offers clinical trials, bioequivalence studies, medical writing, and agrochemical services. Frontage Holdings serves customers in Hong Kong.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
17 Dec 2023 10:10
Hong Kong Connect Flows (Dec 15th): Meituan, Tencent
We analyzed southbound Hong Kong connect flows in the past week and highlight weekly Hong Kong connect flows for Meituan and Tencent.
Ke Yan, CFA, FRM
Follow
444 Views
Share
bullish
•
WuXi XDC Cayman
•
16 Nov 2023 15:32
WuXi XDC IPO: Trading Debut
The market sentiment on the sector has modestly weakened. However, the IPO price is attractive, with our DCF valuation of HK$22.89 per share, 11.1%...
Arun George
Follow
398 Views
Share
bullish
•
WuXi XDC Cayman
•
08 Nov 2023 10:05
WuXi XDC IPO: Valuation Insights
Blue-chip cornerstones will purchase US$300 million of the offer. Our base-case DCF valuation is HK$22.84 per share, 12.8% above the midpoint of...
Arun George
Follow
557 Views
Share
bullish
•
WuXi XDC Cayman
•
06 Nov 2023 21:16
WuXi XDC IPO: Valuation First-Look
WuXi XDC is pre-marketing an HKEx IPO to raise US$500m. In this note, we present our forecasts and take the first look at the potential valuation...
Arun George
Follow
531 Views
Share
bearish
•
WuXi XDC Cayman
•
01 Nov 2023 18:21
WuXi XDC IPO: The Bear Case
The bear case rests on margins on a downward trend, large customer concentration, high related party transactions and volatile FCF generation.
Arun George
Follow
468 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x